文献速递心境障碍焦虑、强迫与应激相关障碍

贯叶金丝桃素作用于TRPC6通道的研究促成新型抗抑郁药开发

Analysis of hyperforin (St. John's wort) action at TRPC6 channel leads to the development of a new class of antidepressant drugs.
PubMed 文献 · Mol Psychiatry · 2022-10-12

研究鉴定瞬时受体电位经典通道6(TRPC6)为调控焦虑抑郁行为且为贯叶金丝桃素抗抑郁作用所必需的靶点;小鼠TRPC6缺失导致焦虑抑郁行为并降低海马CA1锥体神经元和齿状回颗粒细胞兴奋性;合成的贯叶金丝桃素类似物Hyp13通过同一TRPC6机制重现小鼠抗焦虑抑郁效应且不激活孕烷X受体(PXR),从而避免药物相互作用。

要点

  • TRPC6缺失小鼠表现焦虑抑郁行为并降低海马神经元兴奋性。
  • 贯叶金丝桃素经特定结合基序激活TRPC6通道。
  • 类似物Hyp13经TRPC6产生抗焦虑抑郁效应且不激活PXR。

核心结论

  • TRPC6是调控焦虑抑郁行为且为贯叶金丝桃素抗抑郁作用所必需的靶点。
  • 类似物Hyp13通过TRPC6机制重现小鼠抗焦虑抑郁效应且不激活PXR。

研究设计与样本

  • 研究采用小鼠模型,结合TRPC6缺陷、电生理和定向诱变分析贯叶金丝桃素作用。
  • 研究合成贯叶金丝桃素类似物Hyp13并评估其与TRPC6结合及小鼠行为效应。

主要发现

  • 小鼠TRPC6缺陷导致焦虑抑郁行为并降低海马CA1锥体神经元和齿状回颗粒细胞兴奋性。
  • 贯叶金丝桃素通过TRPC6特定结合基序激活通道。
  • Hyp13与TRPC6结合相似并重现TRPC6依赖性抗焦虑抑郁效应。
  • Hyp13不激活PXR,失去诱导药物相互作用的潜力。

临床怎么用

  • TRPC6可作为控制焦虑抑郁行为的可成药靶点。
  • Hyp13类类似物可能为开发避免药物相互作用的抗抑郁药提供新途径。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

St. John's wort is an herb, long used in folk medicine for the treatment of mild depression. Its antidepressant constituent, hyperforin, has properties such as chemical instability and induction of drug-drug interactions that preclude its use for individual pharmacotherapies. Here we identify the transient receptor potential canonical 6 channel (TRPC6) as a druggable target to control anxious and depressive behavior and as a requirement for hyperforin antidepressant action. We demonstrate that TRPC6 deficiency in mice not only results in anxious and depressive behavior, but also reduces excitability of hippocampal CA1 pyramidal neurons and dentate gyrus granule cells. Using electrophysiology and targeted mutagenesis, we show that hyperforin activates the channel via a specific binding motif at TRPC6. We performed an analysis of hyperforin action to develop a new antidepressant drug that uses the same TRPC6 target mechanism for its antidepressant action. We synthesized the hyperforin analog Hyp13, which shows similar binding to TRPC6 and recapitulates TRPC6-dependent anxiolytic and antidepressant effects in mice. Hyp13 does not activate pregnan-X-receptor (PXR) and thereby loses the potential to induce drug-drug interactions. This may provide a new approach to develop better treatments for depression, since depression remains one of the most treatment-resistant mental disorders, warranting the development of effective drugs based on naturally occurring compounds.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. El Hamdaoui Y, Zheng F, Fritz N, et al. Analysis of hyperforin (St. John's wort) action at TRPC6 channel leads to the development of a new class of antidepressant drugs. Mol Psychiatry. 2022. PMID: 36224261. doi:10.1038/s41380-022-01804-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。